Trial
NCT04553263
Relapse Prevention in Stimulant Use Disorder
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
—
Condition
Stimulant Use
Intervention
Contrave 8Mg-90Mg Extended-Release Tablet
Why stopped
Study never initiated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-22